Beacon Pointe Wealth Advisors’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$385K Buy
+6,570
New +$365K 0.07% 186
2019
Q3
Sell
-7,170
Closed -$357K 273
2019
Q2
$357K Buy
7,170
+160
+2% +$8.03K 0.08% 193
2019
Q1
$366K Sell
7,010
-95
-1% -$4.75K 0.08% 185
2018
Q4
$341K Buy
+7,105
New +$350K 0.12% 153

Other funds holding GSK

Beacon Pointe Wealth Advisors's GSK Position: Q4 2019 in Review

Beacon Pointe Wealth Advisors opened a new position in GSK (GSK) in Q4 2019: 6,570 shares worth $385K. The stake represents 0.07% of the portfolio and ranks #186 among its holdings. This is a return to the name: Beacon Pointe Wealth Advisors previously reported a position in GSK as recently as Q2 2019.

Beacon Pointe Wealth Advisors first reported a position in GSK in Q4 2018 and has held it in 4 quarters since. 894 funds tracked by Wall St. Rank hold GSK as of Q4 2019.

  • Beacon Pointe Wealth Advisors held 6,570 shares of GSK worth $385K as of Q4 2019.
  • GSK was a new Beacon Pointe Wealth Advisors position in Q4 2019.
  • GSK made up 0.07% of Beacon Pointe Wealth Advisors's portfolio in Q4 2019, its #186 holding.
  • Beacon Pointe Wealth Advisors first reported a position in GSK in Q4 2018 and has held it in 4 quarters since.
  • 894 funds tracked by Wall St. Rank held GSK as of Q4 2019.

Based on Beacon Pointe Wealth Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.